Monday, April 15, 2024
HomeSide BusinessGlobal Immunoassay Systems Industry to 2027 - Increasing Incidence of Infectious Diseases...

Global Immunoassay Systems Industry to 2027 – Increasing Incidence of Infectious Diseases Presents Opportunities

DUBLIN–(BUSINESS WIRE)–The “Immunoassay Systems – Global Market Trajectory & Analytics” report has been added to’s offering.

Amid the COVID-19 crisis, the global market for Immunoassay Systems estimated at US$21.7 Billion in the year 2020, is projected to reach a revised size of US$29.4 Billion by 2027, growing at a CAGR of 4.4% over the analysis period 2020-2027.

Enzyme Immunoassay, one of the segments analyzed in the report, is projected to record a 4.2% CAGR and reach US$8.8 Billion by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Chemiluminescence Immunoassay segment is readjusted to a revised 5% CAGR for the next 7-year period.

The U.S. Market is Estimated at $5.9 Billion, While China is Forecast to Grow at 7.8% CAGR

The Immunoassay Systems market in the U.S. is estimated at US$5.9 Billion in the year 2020. China, the world’s second largest economy, is forecast to reach a projected market size of US$6.4 Billion by the year 2027 trailing a CAGR of 7.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 1.5% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.3% CAGR.

Rapid Tests Segment to Record 5.2% CAGR

In the global Rapid Tests segment, USA, Canada, Japan, China and Europe will drive the 4.6% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$2.9 Billion in the year 2020 will reach a projected size of US$4 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$4.2 Billion by the year 2027, while Latin America will expand at a 6.2% CAGR through the analysis period.

Select Competitors (Total 65 Featured):

  • Abbott Laboratories
  • Beckman Coulter Inc.
  • bioMerieux SA
  • Bio-Rad Laboratories Inc.
  • DiaSorin S.p.A
  • Ortho-Clinical Diagnostics Inc.
  • Quidel Corporation
  • Roche Diagnostics
  • Siemens Healthineers
  • Sysmex Corporation
  • Tosoh Bioscience Inc.

Key Topics Covered:




  • Influencer Market Insights
  • World Market Trajectories
  • Immunoassay Systems: An Introductory Prelude
  • Recent Market Activity
  • Steady Growth Projected for World Immunoassay Systems Market
  • Expanding Applications Boost Market Prospects
  • Northbound Trajectory in Healthcare Spending Underpins Value Growth
  • Developed Regions – Primary Revenue Contributors
  • Fast Paced Growth Forecasts in Developing Regions
  • Expansion in Healthcare Infrastructure & Rising Healthcare Awareness Fuel Demand in Developing Regions
  • Impact of Covid-19 and a Looming Global Recession



  • Bespoke Solutions Energize Market Growth
  • Multiplex Immunoassays Accelerate Overall Market Expansion
  • ELISA – Preferred Immunoassay Test in Research and Diagnostic Applications
  • Automation of ELISA – Enabling its Sustenance
  • Growing Popularity of Multiplexing Deters ELISA Market
  • Commoditization: A Key Issue Facing ELISA Product Manufacturers
  • Chemiluminescence Immunoassays Gain Prominence
  • Waning Demand for Radioimmunoassay Systems
  • Immunoassays Solidify their Role in Biomarker Detection
  • SERS – An Attractive Readout Strategy
  • Automated Immunoassay Systems – In Line with Automation Trend
  • Point-of-Care (POC) and Digital immunoassay (DIA) Systems Make Substantial Gains
  • Miniaturization Aids Roll Out of Sophisticated POC and DIA Systems
  • Ultra-Sensitive Platforms Set to Proliferate the Market
  • Infectious Disease Diagnosis – Primary Application Area
  • Increasing Incidence of Infectious Diseases – An Opportunity Indicator
  • Growing Significance in Cancer Care
  • Sustained Opportunities in Endocrine Testing Procedures
  • Diabetes Testing
  • Prenatal Testing
  • Vital Role in Blood Processing Applications
  • Blood Grouping and Typing
  • Food Sciences and Quality Control Offer Robust Growth Verticals
  • Growing Prominence of Immunoassays in New & Niche Application Verticals: A Review
  • Environmental Testing
  • Drugs of Abuse Testing (DAT)
  • Therapeutic Drug Monitoring (TDM)
  • Immune Diseases
  • Expanding Use Case in Biomedical Research Processes Amplifies Demand
  • Consolidation of Hospitals and Labs Triggers Robust Growth Opportunities
  • Rising Medical Needs of Aging Population – A Market Driver




For more information about this report visit


Most Popular